logo

For the Inventor, By the Inventor

Grunstadt, Germany

Bernd Muller-Beckmann

This inventor holds 18 USPTO granted patents. Top assignee: Boehringer Mannheim Gmbh. Active years: 1986-1990.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernd Muller-Beckmann. Retrieved from https://idiyas.com/inventor/bernd-muller-beckmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 7

Forward Citations = 154(Granted Patents)


Location History:

  • Grunstadt, DE (1986 - 1990)
  • Grustadt, DE (1987 - 1990)

Company Filing History:

goldMedal18 out of 1,164 
 
Boehringer Mannheim Gmbh
 patents

Years Active: 1986-1990

Loading Chart...
18 patents (USPTO):Explore Patents
1. 4963686 - Certain pyridinoylamino-indolin-2-one derivatives (1990-10-16),
2. 4925845 - 2 heteroaryl 3,3 dialkyl-5-(3 oxo-2,3,4,5 tetrahydro-6 (1990-05-15),
3. 4882342 - 5-alkylbenzimidazoles, method of use and pharmaceutical compositions (1989-11-21),
4. 4880805 - Use of alkylenediamine derivatives for the treatment of blood flow (1989-11-14),
5. 4874756 - Benzodipyrroles, processes for the preparation thereof and (1989-10-17),
6. 4870077 - Heterocyclic substituted indolinones (1989-09-26),
7. 4851406 - Heterocyclic-substituted indoles and pharmaceutical compositions (1989-07-25),
8. 4847251 - Pyridazinone derivatives, and pharmaceutical compositions containing them (1989-07-11),
9. 4835167 - Tricyclic benzotriazoles, processes for the preparation thereof and (1989-05-30),
10. 4831032 - Cardiotonic benzimidazoles (1989-05-16),
11. 4824835 - Isoquinolinedione derivatives, pharmaceutical compositions and methods (1989-04-25),
12. 4810801 - Pyrrolobenzimidazoles, pharmaceutical compositions containing them, and (1989-03-07),
13. 4780474 - Use of alkylenediamine derivatives for the treatment of blood flow (1988-10-25),
14. 4730003 - Tricyclic compounds for treating heart and circulatory diseases (1988-03-08),
15. 4710510 - Pyrrolobenzimidazoles, pharmaceutical compositions containing them, and (1987-12-01),

Title: Bernd Muller-Beckmann: Innovator in Pharmaceutical Chemistry

Introduction

Bernd Muller-Beckmann is a distinguished inventor based in Grunstadt, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 18 patents. His work focuses on innovative compounds that have the potential to improve health outcomes.

Latest Patents

Among his latest patents, Muller-Beckmann has developed certain pyridinoylamino-indolin-2-one derivatives. These compounds are characterized by a complex general formula that includes various substituents, such as hydrogen atoms, alkyl groups, and heteroaryl radicals. The compounds are designed to be useful in reducing blood pressure, producing a positive inotropic action, influencing thrombocyte aggregation, and improving microcirculation. Additionally, he has disclosed hydrazinophenyl heterocyclic intermediates that further enhance the therapeutic potential of his inventions.

Career Highlights

Muller-Beckmann is currently associated with Boehringer Mannheim GmbH, a prominent company in the pharmaceutical industry. His innovative work has positioned him as a key figure in the development of new therapeutic agents. His extensive patent portfolio reflects his commitment to advancing medical science and improving patient care.

Collaborations

Throughout his career, Muller-Beckmann has collaborated with notable colleagues, including Alfred Mertens and Klaus Strein. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmaceutical research.

Conclusion

Bernd Muller-Beckmann is a remarkable inventor whose contributions to pharmaceutical chemistry have the potential to significantly impact healthcare. His innovative patents and collaborations highlight his dedication to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…